Atlas FDA

TrueTear Intranasal Tear Neurostimulator

FDA 510(k) clearance DEN170086 · decided 2018-05-17

Clearance details

K-number
DEN170086
Device name
TrueTear Intranasal Tear Neurostimulator
Applicant
Allergan
Decision
Unknown
Date received
2017-10-23
Decision date
2018-05-17
Days to decision
206 days
Clearance type
Direct
Product code
QBR
Device class
2
Regulation number
886.5310
Medical specialty
Ophthalmic
Advisory committee
Ophthalmic
Location
Irvine, CA, US
Third-party review
No
Expedited review
No

+ Add to Predicate Builder ◉ Watch Allergan

The Builder collects up to 8 candidate devices side by side with yours, then exports the substantial-equivalence comparison scaffold. How it works

Need this as data, not a web page?

Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.

Similar devices under this product code

Devices cleared under the same product code - the starting set for predicate research.

RecordFirmDate
TrueTear Intranasal Tear Neurostimulator (K193589)Allergan2020-08-31

Recalls involving this device

No recalls on record reference this clearance.

PMA approvals by this applicant

RecordFirmDate
Juvéderm Voluma XC, Juvéderm Vollure XC, Juvéderm Volbella XC, Juvéderm Volux XC and SKINVIVE by Juvéderm (hereafter ref (P110033/S101)Allergan2025-08-14
Juvéderm Ultra XC, and Juvéderm Ultra Plus XC (hereafter referred to as Ultra XC and Ultra Plus XC) (P050047/S105)Allergan2025-08-14
Juvéderm Ultra, Juvéderm Ultra XC, and Juvéderm Ultra Plus XC (hereafter referred to as Ultra, Ultra XC and Ultra Plus X (P050047/S104)Allergan2025-07-14
Juvéderm Voluma XC, Juvéderm Vollure XC, Juvéderm Volbella XC, Juvéderm Volux XC and SKINVIVE by Juvéderm (hereafter ref (P110033/S100)Allergan2025-07-14
Juvederm Injectable Gel (P110033/S085)Allergan2025-06-25
JUVEDERM VOLUMA XC (P110033/S098)Allergan2025-05-08
SKINVIVE by Juvéderm (P110033/S097)Allergan2025-05-01
Ultra, Ultra XC, Ultra Plus XC, Ultra XC (P050047/S103)Allergan2025-04-15